Stockscreener 앱 받기
80.27
1.65%
-1.35
시간 외 거래:
80.01
-0.26
-0.32%
Dexcom Inc 주식(DXCM)의 최신 뉴스
Barclays Adjusts DexCom Price Target to $93 From $90, Maintains Equal Weight Rating - marketscreener.com
DexCom (DXCM) Gets Price Target Increase from Barclays | DXCM Stock News - GuruFocus
Should You Buy DXCM Stock At $80? - Forbes
Dexcom revenue grows 12% to USD 1.036 billion in Q1 2025 - Medical Buyer
Barclays Adjusts Price Target for DexCom (DXCM) to $93 Following Q1 Results | DXCM Stock News - GuruFocus
DexCom Stock: Growth Is Reaccelerating But Don't Ignore The Risks (NASDAQ:DXCM) - Seeking Alpha
DexCom (DXCM) Shares Surge on Strong Revenue and Buyback Announcement - GuruFocus
Dexcom Stock Is Today’s Big Winner After Earnings. Why the Medtech is Soaring. - Barron's
Duolingo, CoreWeave And DexCom Are Among Top 10 Large-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio? - Benzinga
DexCom Inc. stock outperforms competitors on strong trading day - MSN
Why DexCom Inc. (DXCM) Soared Last Week - MSN
DexCom, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More InformationDXCM - ACCESS Newswire
Investors who lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class ActionDXCM - ACCESS Newswire
Market Indexes Rise On Strong Payroll Data; DexCom Leads Gains - Finimize
Why DexCom, Inc. (DXCM) Went Up On Friday - Insider Monkey
BTIG raises DexCom stock price target to $109 from $107 By Investing.com - Investing.com South Africa
Sector Update: Health Care - marketscreener.com
DexCom Stock Rockets Higher To Lead S&P 500 Gainers Friday - Investopedia
DexCom (NasdaqGS:DXCM) Announces US$750M Buyback and Reiterates 2025 Earnings Guidance - Yahoo Finance
DexCom Stock Rises Despite Q1 Earnings Miss & Lower Margins - Zacks Investment Research
DexCom (DXCM) Stock Rating Maintained, Price Target Lowered | DXCM Stock News - GuruFocus
Leerink Adjusts Price Target on DexCom to $101 From $95 - marketscreener.com
Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday - Benzinga
DexCom (DXCM): Analyst Maintains Rating but Lowers Price Target - GuruFocus
DexCom (DXCM): Analyst Maintains Rating but Lowers Price Target | DXCM Stock News - GuruFocus
Redburn Atlantic Adjusts DexCom Price Target to $110 From $115 - marketscreener.com
DexCom (DXCM) Target Price Reduced by Baird Amid Mixed Q1 Result - GuruFocus
DexCom, Inc. (NASDAQ:DXCM) Q1 2025 Earnings Call Transcript - Insider Monkey
DexCom (DXCM) Target Price Reduced by Baird Amid Mixed Q1 Results | DXCM Stock News - GuruFocus
DexCom (DXCM) Sees Improved Price Target Following Strong Q1 Per - GuruFocus
DexCom (DXCM) Price Target Increased by Canaccord Following Stro - GuruFocus
DexCom (DXCM) Sees Improved Price Target Following Strong Q1 Performance | DXCM Stock News - GuruFocus
DexCom (DXCM) Price Target Lowered by Piper Sandler | DXCM Stock News - GuruFocus
DexCom (DXCM) Price Target Increased by Canaccord Following Strong Q1 Results | DXCM Stock News - GuruFocus
Decoding DexCom Inc (DXCM): A Strategic SWOT Insight - GuruFocus
DexCom Inc (DXCM) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Supply Challenges - Yahoo Finance
DexCom Inc (DXCM) Q1 2025 Earnings: Revenue Surpasses Estimates - GuruFocus
DXCM STOCK ALERT: A Class Action is Pending Against DexCom, Inc. for Securities Fraud; Contact BFA Law before October 21 Court Deadline if You Lost Money - ACCESS Newswire
Dexcom Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Class Action Filed Against DexCom, Inc. (DXCM) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
Dexcom Reports Strong Q1 2025 Results and Strategic Growth - TipRanks
Press Release Distribution & PR Platform - ACCESS Newswire
DexCom: Q1 Earnings Snapshot - MySA
Earnings call transcript: DexCom Q1 2025 revenue beats expectations By Investing.com - Investing.com Nigeria
Earnings call transcript: DexCom Q1 2025 revenue beats expectations - Investing.com
Dexcom's Growth Fueled By Demand For Innovative Glucose Monitors - Finimize
Compared to Estimates, DexCom (DXCM) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
DexCom (NASDAQ:DXCM) Exceeds Q1 Expectations - Yahoo Finance
DexCom (DXCM) Q1 Earnings Miss Estimates - Yahoo Finance
Dexcom (DXCM) Exceeds Q1 Revenue Expectations with $1.036B | DXC - GuruFocus
DexCom Inc. Announces Fall In Q1 Bottom Line - Nasdaq
1.64%
0.20%
자본화:
|
볼륨(24시간):